EZH2 and neoplasm: The direct O-GlcNAc modification on β-catenin also alters the protein-protein interaction profile of β-catenin, where it promotes the interaction between β-catenin and EZH2, which is a master regulator of the cell cycle and plays a pivotal role in driving tumor initiation, tumor growth, metastasis and drug resistance (107, 108).